Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Persistently abnormal liver function tests: Marker of occult hepatitis C?

05.01.2004


Patients with persistently abnormal liver function tests but no serologic evidence of liver disease may nevertheless have hepatitis C virus (HCV) infection, according to a study published in the January 1 issue of The Journal of Infectious Diseases, available online now.



Such occult (meaning hidden or concealed) infection is not supposed to occur--the conventional wisdom is that the virus leaves markers in serum or plasma, including specific antibodies and viral RNA, which have been the serologic cornerstones for diagnosing and monitoring HCV-infected patients. Although occult HCV infection generally appears to be mild, some patients have shown evidence of serious chronic liver injury. In addition, occult infection raises the possibility of disease spread via blood donations, hemodialysis and other procedures. Fortunately, the study also suggests a minimally invasive approach to detect occult infection.

The study, reported by a group headed by Vicente Carreño, MD, in Madrid, Spain, involved 100 patients with abnormally high levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT) or gamma glutamyl transpeptidase (GGTP) for at least 12 months in whom all causes of liver disease, including HCV infection, had ostensibly been excluded. All three liver enzymes were elevated in eight patients, two of the enzymes in 48 and one enzyme in 44. For comparison, 30 patients with liver damage known to be of non-viral origin were also studied.


The investigators relied on two assays to demonstrate the presence or absence of HCV infection. First, using reverse transcription-polymerase chain reaction (RT-PCR) with primers from one region of the HCV genome, they detected the virus’s RNA in liver biopsies from 57 (57%) of the patients with abnormal liver enzymes of unknown etiology, compared to none of the biopsies from control patients. When primers from another region of the genome were used in the RT-PCR assay, HCV RNA was found in liver biopsies from 40 (70%) of the 57 patients. The second method used was in situ hybridization, which demonstrated positive-strand HCV RNA in liver biopsies from the same 57 patients, but in none of those from the controls, and negative-strand HCV RNA in 48 (84%). The investigators noted that the latter finding suggested viral replication, which involves synthesis of a negative RNA intermediary.

The RT-PCR assay also detected HCV RNA in peripheral-blood mononuclear cells from 40 (70%) of the 57 patients with occult infection. The clinical implication of this finding, the investigators noted, is that a high percentage of patients with occult HCV infection may be more easily and more safely identified by obtaining and testing blood cells rather than liver cells.

In an accompanying editorial, Hervé Lerat, MD, and F. Blaine Hollinger, MD, of Baylor College of Medicine, Houston, commented that the distribution of hepatic enzyme elevations in the study population implied that clinicians should use both ALT and GGT to identify patients who may qualify for peripheral-blood mononuclear cell testing for occult HCV infection. They cautioned, however, that many issues about such infections remain to be resolved, including the central issue of whether the detected viral genomic material is infectious.


Founded in 1904, The Journal of Infectious Diseases (JID) is the premier publication in the Western Hemisphere for original research on the pathogenesis, diagnosis and treatment of infectious diseases; on the microbes that cause them; and on disorders of host immune mechanisms. Articles in JID include research results from microbiology, immunology, epidemiology and related disciplines. JID is published under the auspices of the Infectious Diseases Society of America (IDSA), based in Alexandria, Va., a professional society representing more than 7,000 physicians and scientists who specialize in infectious diseases.

Note: Interviews with Drs. Carreño and Hollinger can be arranged by contacting Diana Olson at dolson@idsociety.org or 703-299-0201.

Diana Olson | EurekAlert!
Further information:
http://www.idsociety.org/

More articles from Health and Medicine:

nachricht Plasmonic biosensors enable development of new easy-to-use health tests
14.12.2017 | Aalto University

nachricht ASU scientists develop new, rapid pipeline for antimicrobials
14.12.2017 | Arizona State University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Long-lived storage of a photonic qubit for worldwide teleportation

MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.

Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...

Im Focus: Electromagnetic water cloak eliminates drag and wake

Detailed calculations show water cloaks are feasible with today's technology

Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...

Im Focus: Scientists channel graphene to understand filtration and ion transport into cells

Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.

To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...

Im Focus: Towards data storage at the single molecule level

The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.

Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...

Im Focus: Successful Mechanical Testing of Nanowires

With innovative experiments, researchers at the Helmholtz-Zentrums Geesthacht and the Technical University Hamburg unravel why tiny metallic structures are extremely strong

Light-weight and simultaneously strong – porous metallic nanomaterials promise interesting applications as, for instance, for future aeroplanes with enhanced...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

 
Latest News

Plasmonic biosensors enable development of new easy-to-use health tests

14.12.2017 | Health and Medicine

New type of smart windows use liquid to switch from clear to reflective

14.12.2017 | Physics and Astronomy

BigH1 -- The key histone for male fertility

14.12.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>